Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
ADMA |
|
PDUFA |
Autoimmune |
None |
|
09/14/2016
|
ARLZ |
|
PDUFA |
Cardiovascular |
None |
|
07/24/2016
|
OCUL |
|
PDUFA |
Opthamology |
None |
|
Q4 2016
|
OPXA |
|
Phase 2b Results |
Autoimmune |
None |
|
Q2 2016
|
TBRA |
|
Phase 2a Results |
Endocrine |
Fast Track |
|
Q3 2016
|
TBRA |
|
Phase 2b Results |
Endocrine |
Fast Track |
|
Q2 2016
|
RIGL |
|
Phase 3 Results |
Autoimmune |
None |
|
Q3 2016
|
RIGL |
|
Phase 3 Results |
Autoimmune |
None |
|
Q4 2016
|
RIGL |
|
Phase 2 Results |
Autoimmune |
None |
|
Q4 2016
|
RIGL |
|
Phase 2 Results |
Autoimmune |
None |
|